Literature DB >> 15255945

Increased cerebral uptake and oxidation of exogenous betaHB improves ATP following traumatic brain injury in adult rats.

M L Prins1, S M Lee, L S Fujima, D A Hovda.   

Abstract

There is growing evidence of the brain's ability to increase its reliance on alternative metabolic substrates under conditions of energy stress such as starvation, hypoxia and ischemia. We hypothesized that following traumatic brain injury (TBI), which results in immediate changes in energy metabolism, the adult brain increases uptake and oxidation of the alternative substrate beta-hydroxybutyrate (betaHB). Arterio-venous differences were used to determine global cerebral uptake of betaHB and production of 14CO2 from [14C]3-betaHB 3 h after controlled cortical impact (CCI) injury. Quantitative bioluminescence was used to assess regional changes in ATP concentration. As expected, adult sham and CCI animals with only endogenously available betaHB showed no significant increase in cerebral uptake of betaHB or 14CO2 production. Increasing arterial betaHB concentrations 2.9-fold with 3 h of betaHB infusion failed to increase cerebral uptake of betaHB or 14CO2 production in adult sham animals. Only CCI animals that received a 3-h betaHB infusion showed an 8.5-fold increase in cerebral uptake of betaHB and greater than 10.7-fold increase in 14CO2 production relative to sham betaHB-infused animals. The TBI-induced 20% decrease in ipsilateral cortical ATP concentration was alleviated by 3 h of betaHB infusion beginning immediately after CCI injury.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15255945     DOI: 10.1111/j.1471-4159.2004.02542.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  48 in total

1.  Ketogenic diet prevents alterations in brain metabolism in young but not adult rats after traumatic brain injury.

Authors:  Ying Deng-Bryant; Mayumi L Prins; David A Hovda; Neil G Harris
Journal:  J Neurotrauma       Date:  2011-08-04       Impact factor: 5.269

Review 2.  Molecular and physiological responses to juvenile traumatic brain injury: focus on growth and metabolism.

Authors:  Talin Babikian; Mayumi L Prins; Yan Cai; Garni Barkhoudarian; Ivet Hartonian; David A Hovda; Christopher C Giza
Journal:  Dev Neurosci       Date:  2010-11-12       Impact factor: 2.984

Review 3.  Neuroprotective and disease-modifying effects of the ketogenic diet.

Authors:  Maciej Gasior; Michael A Rogawski; Adam L Hartman
Journal:  Behav Pharmacol       Date:  2006-09       Impact factor: 2.293

Review 4.  Cerebral metabolic adaptation and ketone metabolism after brain injury.

Authors:  Mayumi L Prins
Journal:  J Cereb Blood Flow Metab       Date:  2007-08-08       Impact factor: 6.200

Review 5.  Ketogenic diets, mitochondria, and neurological diseases.

Authors:  Lindsey B Gano; Manisha Patel; Jong M Rho
Journal:  J Lipid Res       Date:  2014-05-20       Impact factor: 5.922

6.  Pyruvate treatment attenuates cerebral metabolic depression and neuronal loss after experimental traumatic brain injury.

Authors:  Nobuhiro Moro; Sima S Ghavim; Neil G Harris; David A Hovda; Richard L Sutton
Journal:  Brain Res       Date:  2016-04-06       Impact factor: 3.252

7.  The effects of a ketogenic diet on behavioral outcome after controlled cortical impact injury in the juvenile and adult rat.

Authors:  K Sofia Appelberg; David A Hovda; Mayumi L Prins
Journal:  J Neurotrauma       Date:  2009-04       Impact factor: 5.269

8.  Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer's disease: a randomized, double-blind, placebo-controlled, multicenter trial.

Authors:  Samuel T Henderson; Janet L Vogel; Linda J Barr; Fiona Garvin; Julie J Jones; Lauren C Costantini
Journal:  Nutr Metab (Lond)       Date:  2009-08-10       Impact factor: 4.169

9.  Insulin-dependent diabetes and serious trauma.

Authors:  D Z Liou; M B Singer; G Barmparas; M Y Harada; J Mirocha; M Bukur; A Salim; E J Ley
Journal:  Eur J Trauma Emerg Surg       Date:  2015-08-08       Impact factor: 3.693

Review 10.  Ketone bodies as a therapeutic for Alzheimer's disease.

Authors:  Samuel T Henderson
Journal:  Neurotherapeutics       Date:  2008-07       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.